OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival
Charles Marcus, Alexander Antoniou, Arman Rahmim, et al.
Journal of Medical Imaging and Radiation Oncology (2015) Vol. 59, Iss. 3, pp. 281-288
Closed Access | Times Cited: 20
Charles Marcus, Alexander Antoniou, Arman Rahmim, et al.
Journal of Medical Imaging and Radiation Oncology (2015) Vol. 59, Iss. 3, pp. 281-288
Closed Access | Times Cited: 20
Showing 20 citing articles:
PET/CT in the management of differentiated thyroid cancer
Emilia Zampella, Michele Klain, Leonardo Pace, et al.
Diagnostic and Interventional Imaging (2021) Vol. 102, Iss. 9, pp. 515-523
Open Access | Times Cited: 58
Emilia Zampella, Michele Klain, Leonardo Pace, et al.
Diagnostic and Interventional Imaging (2021) Vol. 102, Iss. 9, pp. 515-523
Open Access | Times Cited: 58
PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art
Arnoldo Piccardo, Pierpaolo Trimboli, Luca Foppiani, et al.
Reviews in Endocrine and Metabolic Disorders (2019) Vol. 20, Iss. 1, pp. 47-64
Closed Access | Times Cited: 47
Arnoldo Piccardo, Pierpaolo Trimboli, Luca Foppiani, et al.
Reviews in Endocrine and Metabolic Disorders (2019) Vol. 20, Iss. 1, pp. 47-64
Closed Access | Times Cited: 47
Investigating 18F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review
Hongxi Wang, Hongyuan Dai, Qianrui Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Hongxi Wang, Hongyuan Dai, Qianrui Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Prognostic Role of 2-[18F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative 131I WBS and Positive 2-[18F]-FDG PET/CT
Domenico Albano, Francesco Dondi, Angelica Mazzoletti, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2189-2189
Open Access | Times Cited: 20
Domenico Albano, Francesco Dondi, Angelica Mazzoletti, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2189-2189
Open Access | Times Cited: 20
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
Barbara Salvatore, Michele Klain, Emanuele Nicolai, et al.
Medicine (2017) Vol. 96, Iss. 42, pp. e8344-e8344
Open Access | Times Cited: 24
Barbara Salvatore, Michele Klain, Emanuele Nicolai, et al.
Medicine (2017) Vol. 96, Iss. 42, pp. e8344-e8344
Open Access | Times Cited: 24
The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan
Adam Stangierski, Jarosław Kaznowski, Kosma Woliński, et al.
Nuclear Medicine Communications (2016) Vol. 37, Iss. 9, pp. 935-938
Closed Access | Times Cited: 17
Adam Stangierski, Jarosław Kaznowski, Kosma Woliński, et al.
Nuclear Medicine Communications (2016) Vol. 37, Iss. 9, pp. 935-938
Closed Access | Times Cited: 17
Positron Emission Tomography/Computed Tomography in Thyroid Cancer
Chandrasekhar Bal, Dhritiman Chakraborty, Dikhra Khan
PET Clinics (2022) Vol. 17, Iss. 2, pp. 265-283
Closed Access | Times Cited: 8
Chandrasekhar Bal, Dhritiman Chakraborty, Dikhra Khan
PET Clinics (2022) Vol. 17, Iss. 2, pp. 265-283
Closed Access | Times Cited: 8
Prognostic role of FDG ‐PET /CT in differentiated thyroid carcinoma: Where are we now?
Giorgio Treglia, Luca Giovanella
Journal of Medical Imaging and Radiation Oncology (2015) Vol. 59, Iss. 3, pp. 278-280
Closed Access | Times Cited: 10
Giorgio Treglia, Luca Giovanella
Journal of Medical Imaging and Radiation Oncology (2015) Vol. 59, Iss. 3, pp. 278-280
Closed Access | Times Cited: 10
Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine
Xieyi Zhang, Tetsuya Higuchi, Hiroyasu Tomonaga, et al.
Nuclear Medicine Communications (2020) Vol. 41, Iss. 4, pp. 350-355
Closed Access | Times Cited: 8
Xieyi Zhang, Tetsuya Higuchi, Hiroyasu Tomonaga, et al.
Nuclear Medicine Communications (2020) Vol. 41, Iss. 4, pp. 350-355
Closed Access | Times Cited: 8
Quantification and reduction of respiratory induced artifacts in positron emission tomography/computed tomography using the time-of-flight technique
Roya Sharifpour, Pardis Ghafarian, Arman Rahmim, et al.
Nuclear Medicine Communications (2017) Vol. 38, Iss. 11, pp. 948-955
Closed Access | Times Cited: 7
Roya Sharifpour, Pardis Ghafarian, Arman Rahmim, et al.
Nuclear Medicine Communications (2017) Vol. 38, Iss. 11, pp. 948-955
Closed Access | Times Cited: 7
Clinical utility of 18F-FDG PET/CT in the follow-up of a large cohort of patients with high-risk differentiated thyroid carcinoma
Ji H. Yang, Rui M. B. Maciel, Cláudia C. D. Nakabashi, et al.
Archives of Endocrinology and Metabolism (2017) Vol. 61, Iss. 5, pp. 416-425
Open Access | Times Cited: 7
Ji H. Yang, Rui M. B. Maciel, Cláudia C. D. Nakabashi, et al.
Archives of Endocrinology and Metabolism (2017) Vol. 61, Iss. 5, pp. 416-425
Open Access | Times Cited: 7
Assessment of the Role of Different Imaging Modalities with Emphasis on Fdg Pet/Ct in the Management of Well Differentiated Thyroid Cancer (WDTC)
Tuba Karagulle Kendi A, Shwetha Mudalegundi, Jeffrey M. Switchenko, et al.
Journal of Thyroid Disorders & Therapy (2016) Vol. 05, Iss. 01
Open Access | Times Cited: 6
Tuba Karagulle Kendi A, Shwetha Mudalegundi, Jeffrey M. Switchenko, et al.
Journal of Thyroid Disorders & Therapy (2016) Vol. 05, Iss. 01
Open Access | Times Cited: 6
Biomarkers and Molecular Imaging in Postoperative DTC Management
Domenico Albano, Francesco Dondi, Pietro Bellini, et al.
Springer eBooks (2023), pp. 129-142
Closed Access | Times Cited: 2
Domenico Albano, Francesco Dondi, Pietro Bellini, et al.
Springer eBooks (2023), pp. 129-142
Closed Access | Times Cited: 2
I‐PET score: Combining whole body iodine and 18F‐FDG PET/CT imaging to predict progression in structurally or biochemically incomplete thyroid cancer
Ayanthi Wijewardene, Jeremy Hoang, Aung Min Maw, et al.
Clinical Endocrinology (2022) Vol. 98, Iss. 3, pp. 436-446
Open Access | Times Cited: 4
Ayanthi Wijewardene, Jeremy Hoang, Aung Min Maw, et al.
Clinical Endocrinology (2022) Vol. 98, Iss. 3, pp. 436-446
Open Access | Times Cited: 4
Impact of FDG-PET on therapy management and outcome of differentiated thyroid carcinoma patients with elevated thyroglobulin despite negative iodine scintigraphy
Philipp Backhaus, Alexis Vrachimis, Marie Carolin Schleupner, et al.
Nuklearmedizin - NuclearMedicine (2020) Vol. 59, Iss. 05, pp. 356-364
Closed Access | Times Cited: 5
Philipp Backhaus, Alexis Vrachimis, Marie Carolin Schleupner, et al.
Nuklearmedizin - NuclearMedicine (2020) Vol. 59, Iss. 05, pp. 356-364
Closed Access | Times Cited: 5
The current and evolving role of FDG–PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer
Leonardo Pace, Michele Klain, Luca Tagliabue, et al.
Clinical and Translational Imaging (2017) Vol. 5, Iss. 6, pp. 533-544
Closed Access | Times Cited: 4
Leonardo Pace, Michele Klain, Luca Tagliabue, et al.
Clinical and Translational Imaging (2017) Vol. 5, Iss. 6, pp. 533-544
Closed Access | Times Cited: 4
Thyroid and Parathyroid Cancer
Luca Giovanella, Pierpaolo Trimboli, Alfredo Campennì, et al.
Springer eBooks (2023), pp. 45-79
Closed Access | Times Cited: 1
Luca Giovanella, Pierpaolo Trimboli, Alfredo Campennì, et al.
Springer eBooks (2023), pp. 45-79
Closed Access | Times Cited: 1
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Xieyi Zhang, Tetsuya Higuchi, Arifudin Achmad, et al.
European Journal of Hybrid Imaging (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Xieyi Zhang, Tetsuya Higuchi, Arifudin Achmad, et al.
European Journal of Hybrid Imaging (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 2
A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [18F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer
Hong Hua Piao, Subin Jeon, Su Woong Yoo, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 836-836
Open Access | Times Cited: 1
Hong Hua Piao, Subin Jeon, Su Woong Yoo, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 836-836
Open Access | Times Cited: 1
Imaging Modalities in the Diagnosis of Recurrent or Metastatic Thyroid Cancer
Jorge D. Oldan, Jenny K. Hoang, Terence Z. Wong
Springer eBooks (2017), pp. 233-254
Closed Access
Jorge D. Oldan, Jenny K. Hoang, Terence Z. Wong
Springer eBooks (2017), pp. 233-254
Closed Access
